chrisvoncsefalvay/vaers-outcomes huggingface dataset:
HIGH FEVER; VERY WEAK; FEELING TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 07-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced high fever. On MAR-2021, the subject experienced very weak. On MAR-2021, the subject experienced feeling tired. Laboratory data included: Body temperature (NR: not provided) 102.5. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the high fever, very weak and feeling tired was not reported. This report was non-serious.
The PROQUAD also suffered from a non supported temperature excursion.; No additional AE; HCP called to report that the patient was given PROQUAD instead of MMR II.; This spontaneous report was received from pharmacist and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 09-JUN-2023, the patient was vaccinated with measles, mumps, rubella, and varicella (OKA-MERCK) virus vaccine live (PROQUAD) therapy type: rHA, valid lot #W029552, expiration date: 14-MAR-2024, administered for prophylaxis (strength, and route of administration were not provided), instead of measles, mumps, and rubella (WISTAR RA 27-3) virus vacc, live (MMR II). The measles, mumps, rubella, and varicella (OKA-MERCK) virus vaccine live (PROQUAD) vaccine suffered from a non-supported temperature excursion, with temperature of 8 C, during a time frame of 1872 hours. No additional information or adverse event was reported.
Fatigue, body aches, soreness at injection site in both arms though worse in covid arm, and swollen and sore lymph nodes in left armpit (same side as covid vax), and slight headache.
4-5 pustules on (L) thigh 9 days s/p VARIVAX, also quarter size red area at injection site.
Patient first dose was Moderna vaccine on 2-23-21. When he came back for his second dose he accidently received the Pfizer and he was aware his series is complete.
pt received vaccine at about 3:50pm and went over to shop rite across the street. Pt said at about 45 mins later she started to get stiff neck. pt is complaining of pain from back of her neck to left side of the shoulder. Pt states she started feeling something coming soon as she left pharmacy.
LEFT UPPER ARM - RED, WARM, EDEMATOUS ALMOST ENTIRE ANTERIOR AND LATERAL HUMERUS, NO LYMPHADENOPATHY, NONTENDER, NO FLUCTUANCE, NO EXCORIATIONS, NO DISCHARGE OR CRUSTING NOTED. PRESCRIBED ANTIBIOTICS IF RASH SPREADING.
Formation of blisters on various parts of the body; Breaking up of the skin; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Formation of blisters on various parts of the body) and RASH (Breaking up of the skin) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced BLISTER (Formation of blisters on various parts of the body) and RASH (Breaking up of the skin). The patient was treated with GRAMICIDIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORINE) ongoing since an unknown date for Blisters, at an unspecified dose and frequency. At the time of the report, BLISTER (Formation of blisters on various parts of the body) and RASH (Breaking up of the skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. A patient called and reported that she received first doses of vaccine on 23 Feb 2021. After three days she reported to have breaking up of the skin and formation of blisters on various parts of the body. She applied some Neosporin to the blisters. She wanted to know whether she can take any other medications like a steroid for the blisters
TEMPERATURE EXCURSION, VACCINE WAS STORED IN THE FREEZER LONGER THAN THE RECOMMENDED MANUFACTURE TIME FRAME.
two other people who had similar thyroid problems; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THYROID DISORDER (non-serious), outcome "unknown", described as "two other people who had similar thyroid problems".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.  Additional information: During the call, the caller mentioned that her first dose was on 15Apr and the second on 06May, and that in Oct she started to feel sick so she went to see her doctor who diagnosed her with hyperthyroidism, for which she received treatment for a month and a half (6 weeks) and that she had returned to normal values since then. The reporter stated that she knew of two other people who had similar thyroid problems after receiving the vaccine. She mentioned that she found it curious that it is transient, that she knows other people with a similar problem and that she presented with no family history of hyperthyroidism.
This spontaneous report as received from an office administer (also reported as an office manager) refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was reported. On 11-JUL-2016, the patient was vaccinated with an improperly stored dose (the call was because of a data logger, lowest reached temperature: 32 Fahrenheit degrees, time frame: 57 hours) of ROTATEQ lot # L039638 expiration date 23-AUG-2017, orally (dose was not reported). There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information ha been requested.
Flu like symptoms-fever, headaches, body aches, chills and hot and sweats began the following day after shot
Tried to exercise as usual by running a four mile distance, but almost immediately discovered that my lungs were unable to process oxygen deeply.  Feeling was similar to extreme altitude sickness, and while I usually can run four miles at a moderate pace without stopping at all, I found that I had to stop every few hundred yards and gasp for breath.  Even going up stairs caused me to be short of breath.  These symptoms worsened until about 09/20/2015, and have very gradually improved since.  However, as of today (six weeks after injection) lung capacity under physical stress/moderate exercise is still no greater than about 90% by approximate feeling of patient, and for now seems to have leveled without recent further improvement.  It is still impossible for me to exercise as I did pre-Prevnar 13 injection without stopping at least four or five times during a four mile run to walk and catch my breath, and even while running there is a constant feeling as though my lungs are not very deeply utilizing oxygen as they should be. It's noted that the Prevnar 13 injection was given at the Pharmacy, about a half hour after receiving a seasonal flu shot, and after discussion between the employee providing the injection and the head pharmacist.  After experiencing symptoms I've read the cautions by the Prevnar 13 manufacturer which appears to warn against doing these at the same time.  Although the Prevnar 13 was suggested by Dr at the same Clinic during an annual physical earlier that day, neither he nor his immediate staff were responsible for actually performing the injections, nor were they in the decision-making process of the advisability to give both the Prevnar 13 and seasonal flu serums at the same time.  Unknown now whether full lung capacity will return.
Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions; Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions; Patient is Pregnant and received Moderna Covid-19 vaccine; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and MATERNAL EXPOSURE DURING PREGNANCY (Patient is Pregnant and received Moderna Covid-19 vaccine) in a 39-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 07-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and MATERNAL EXPOSURE DURING PREGNANCY (Patient is Pregnant and received Moderna Covid-19 vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions). On 07-Mar-2022, MATERNAL EXPOSURE DURING PREGNANCY (Patient is Pregnant and received Moderna Covid-19 vaccine) had resolved. At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication were provided It was not known which arm the patient received the vaccine. The Nurse reported no adverse reactions or side effects to the Moderna Covid-19 vaccine.
Client was given pfizer covid vaccine that had expired 7 days before it was administered. No adverse events reported. No treatment required. Per guidelines, dose is required to be repeated immediately. Parent/guardian notified, they will talk to child's PCP and oncologist to determine if child will have dose repeated..
The day i received my vaccination, I was just a bit dizzy & tired. The following day I had a sore throat muscle pain, & was vomiting every 3 hours or so. Then the next day after that I no longer had a sore throat but instead had a congested nose, was coughing snot, had a fever over 103°, & couldn?t breathe, had muscle pain & I still threw up but it was only twice that day, also I drank 10 ml of children?s liquid tylennol cherry flavored to try & reduce the fever, it didn?t really help. The next day after that ( which is right now at the time of typing this) I still had a fever but it?s not as bad as yesterday?s, still am coughing snot & have a congested nose, but i can now sort of breathe & am no longer throwing up & no longer have muscle pain, also today i drank Mucinex Children?s Multi-symptom daytime cold, flu, & sore throat medicine, elderberry flavored. I drank that twice today in 10ml doses. It really didn?t do anything & I still feel sick.  I?m not sure if I have covid because i can still taste stuff.
Patient states that approx 2 days after receiving vaccine, her inner arm had redness, swelling, and warmth to the touch. She said that she felt weak. The weakness lasted for 2 days. She said the issue was completely resolved after approx 5 days. She did not have a reaction to the first dose she received.
DIED; This spontaneous report received from a consumer via social media via a company representative concerned multiple patients (5 patients) of unspecified age, race and ethnicity.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 in total for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, five patients died from unknown cause of death. As per the report, it was stated as "I know 5 who have died from the jab too. its terrible the info we are fed" (Dose number in series 1). It was unknown if an autopsy was performed.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211260837-COVID-19 VACCINE AD26.COV2.S-Died. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
enlarged lymph nodes; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team for a Pfizer sponsored program (159558).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (COVID-19 Vaccine, First dose), for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "enlarged lymph nodes".  Additional information: Caller was tested positive for COVID after receiving the first dose of the Pfizer vaccine. Caller read some information stating that the second dose should be administered 10 days after the infection. She also read information to delay the second dose for 90 days if you test positive for COVID before you get your fist dose. Caller wanted to know what was the recommended period to wait before you get your second dose if you test positive for COVID (90 days or 10 days). Caller also had two patients who had enlarged lymph nodes after getting their second dose of the Pfizer vaccine. I have two patient who had enlarged lymph nodes for 3 weeks. They have taken medications and consulted their doctors. Also want to know if Pfizer has any recommendations to bring down the enlarged lymph nodes and want to know how long this symptom last. "Swollen lymph nodes (lymphadenopathy), which generally resolved within 10 days, is likely to have resulted from a robust vaccine-elicited immune response.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a physician via sales rep and described the occurrence of chills in a adult patient who received SHINGRIX. On 17th April 2018, the patient received the 1st dose of SHINGRIX. On 17th April 2018, less than a day after receiving SHINGRIX, the patient experienced chills, nausea, dizziness and general body pain. In April 2018, the outcome of the chills, nausea, dizziness and general body pain were recovered/resolved. The reporter considered the chills, nausea, dizziness and general body pain to be possibly related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. On 17th April 2018, the patient received the initial SHINGRIX vaccine in the doctor's office and late afternoon on the same day, the patient experienced chills, body aches, nausea and dizziness. This information was left by the physician the after hour on voicemail.
Sore throat, low grade fever, night sweats, body aches, sinus drippings.
Sore gland and down hill from there; Breathing / has been awful; Buildup of phlegm has been awful; Feeling absolutely horrible after the flu shot; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. In 2020, 1 day after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pain, difficulty breathing, phlegm and feeling bad. On an unknown date, the outcome of the pain, difficulty breathing, phlegm and feeling bad were unknown.   It was unknown if the reporter considered the pain, difficulty breathing, phlegm and feeling bad to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient will not going to get the flu vaccine again.  It never fails, the patient feel so bad for about 5 or 6 days afterward, and that couldn't be right, the patient had gotten it because breathing was somewhat compromised. However after the patient received the flu vaccine again this year breathing and buildup of phlegm has been awful.  The patient felt great the day of getting it and next day, it started with a sore gland, and down hill from there.  For tolerance in other shot of Flu vaccine refer case US2020AMR199564.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR199564:Same reporter
Onset of fever 103-104 x 2 days;Monday AM no fever, Noon Mon 15APR fever 105 ER visit; rx'd Advil to alternate w/APAPq2hr; 2nd time this has happened p/shot & mom neglected to tell RN of lst time;
Patient was found unconscious on floor very soon after getting up the next day.  Patient was twitching with eyes open and unresponsive.   Very hard to find pulse that day, the next day lightheaded and dizzy, pulse at 60 as measured by spouse and the following day, heart racing and pulse at 90, again as measured by spouse. continued heart pressure/soreness for at least 10 days.  , light headed, foggy for 5 days. Headaches, extreme fatigue for longer
Pt stated pt got 1st covid vaccine Pfizer 4/29/2021 and pt got hives on left arm, rapid heartbeat after 6 hours from covid vaccine 4/29/2021. Pt also said tiredness, headache, chills after covid vaccine but pt didn't take any medications. Pt said hives and rapid heartbeat went away in couple of days without taking benadryl nor any medication, treatments. Noted pt is allergic to malaria medication with hallucination, dental anesthesia mediation with hives, bad fish allergy. Pt already made appt with her PCP(outside) and MD recommended pt to get tested for allergy lab with allergy specialist MD. recommended pt to f/u with PCP/Allergy specialist MD prior to 2nd covid vaccine.
Approximately 24 hours after the booster shot (#3) I started feeling stiffness in my joints and muscles. It lasted about 48 hours and then subsided. It started again approximately 2-3 days later and was so painful it woke me from my sleep. It has continued in this pattern since that time. I have sore achy joints and muscles, to the point where I struggle picking up objects and getting myself into bed/onto couches/etc. I am also experiencing an elevated heart rate. My normal Resting Heart Rate is 54 BPM and it is elevating to over 100 while sitting still. This has also been something that has been happening consistently for the past 2 weeks.
Patient stated that after receiving the vaccine, he had regular arm pain. The arm pain then radiated to his shoulder and eventually down to his elbow in the coming days. He is still experiencing pain from his shoulder to elbow and cannot lift his arm past his shoulder without severe pain.
Revaccination: Dose 4 given 7 days after recommended manufacturer expiration date of vial.
Patient broke out in shingles 8 days after vaccination. Reports mild pain and extreme itching around the torso and then down into the legs. This lasted about 6 weeks.
Systemic: Chills-Medium, Systemic: Confusion-Severe, Additional Details: The patient felt delirious after her 4th dose of the Pfizer COVID vaccine which lasted 3 days. The 4th day she tested positive for COVID. She wanted me to report her adverse effects because her previous doses she did not have any adverse effects.
Headache, Myalgia, Arthralgia & Fever Narrative:  headache, chills, fever, severe myalgia
Client called today, stating she had just noticed a rash around the site of injection, also c/o itching from rash. NO fever or other symptoms.
Information has been received from a 74 year old female pt with "allergies" and who is currently on estrogens, conjugated (Premarin), who on 04/07/04 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine.  Concomitant therapy included estrogens, conjugated (Premarin). The pt reported that 11 days after the vaccination (04/18/04), she experienced fever 99-100 (for the past 4 days), severe rash, nausea, vomiting, inundated clear mucous and coughing continuously. She reported that the physician gave her the vaccination "to build up her immunities". No further information was given. There was no treatment required and no product quality complaint reported. Unspecified medical attention was sought. Additional information has been requested.  Additional information received from the physician's office, on form completed 7/29/05. The physician had said the patient did not have an allergic reaction to the pneumococcal 23v polysaccharide vaccine. The physican saw the patient for chronic sinusitis. The patient saw another physician and reported that they thought it was "maybe a reaction".
Child came into clinic for school physical/well child/immunizations 6/30/2023. Previous nurse whom no longer works in clinic had prepared immunizations after parental and provider orders were given. I assisted on helping previous nurse enter immunizations into patients chart. Was missed that patient received Tdap instead of Dtap. This was later found out 8/24/2023 after school nurse was going through students immunizations and came across it. Provider contacted mother of patient to notify of error and mother assured patient is asymptomatic. She was appreciated of office reaching out to notify her.
Fever within the first 24 hours, in the second 24 hours developed cutaneous erythema multiforme.  He was ultimately hospitalized because of vomiting and diarrhea.  He was treated with prednisolone
Patient came in requesting 4th dose after receiving 3 doses Pfizer, wanting to switch to Moderna.  This was our first patient requesting a 4th dose.  He said his Oncologist recommended he get a "full dose".  He was able to register on the website for it.  (Staff had not received any notification that our clinic would be starting 4th doses for the immunocompromised yet).  We later learned from the CDC recommendations that a booster dose (.25 ml) be given for the 4th dose.      I spoke to patient today, he is happy with the dose he received and is not having any unusual side-effects.
I went into AFib had to go to Hospital by ambulance given medicines had to spend the night to get heart rate back to normal and out of afib, give medicines A liquid and Lopressor to take daily, I was in bed felt funny got up took Blood pressure and Heart rate both was extremely high called ambulance
I started getting symptoms of nasal issues like an allergy. I had aches as well. I got a positive COVID-19 test. I contacted my doctor and was prescribed Paxlovid for 5 days. The body aches went away the next day but I did have nasal congestion. I had mild symptoms. Then around 6/26/2022, I had a relapse. I had a lot of nasal congestion and tiredness. Those symptoms lasted for about 1 day.